SPOTLIGHT: Avastin misses in pancreatic cancer trial


In other Avastin news, Roche announced that a late-stage trial of the drug in pancreatic cancer didn't meet its primary endpoint. Report

Suggested Articles

With AbbVie's two most recent launches outperforming expectations, investors could be looking at a steal with an Allergan merger looming.

Investors are clamoring for a CVR created in the BMS-Celgene deal, but it will only pay off if the FDA approves three hot pipeline projects.

Muzammil Mansuri, Sanofi’s EVP of strategy and business development since February 2016, is retiring at the end of November.